-The number of systems of care for quickly transferring and treating heart attack patients has increased substantially.
-Survey findings show similar characteristic in successful regional care systems and will be a benchmark for expanding the American Heart Association’s Mission: Lifeline® STEMI program, launched five years ago.
DALLAS ― The number of systems of care that quickly transfer and treat heart attack
patients has increased substantially across the nation, according to research published in Circulation: Cardiovascular Quality and Outcomes,
an American Heart Association journal.
Each year in the United States, nearly 300,000 people have a STEMI, which occurs when a blood clot completely blocks an artery to the heart. To prevent death, it’s critical to immediately restore blood flow, either by surgically opening the blocked vessel or by giving clot-busting medication.
Ideally, the initial 9-1-1 call activates the STEMI system
when someone suffers a heart attack. The continuum includes the care patients receive in route to and at hospitals.
Between April 2008 and January 2010, 381 STEMI-care systems, representing 899 hospitals in 47 states, responded to the Mission: Lifeline survey. Systems included at least one hospital that performs the artery-opening procedure percutaneous coronary intervention
(PCI) and one emergency medical service (EMS) group.
Two-thirds (67 percent) of the systems were in urban areas and most followed standard quality procedures and policies, including:
- Admitting STEMI patients even when a hospital bed was not readily available (97 percent).
- Requiring a single phone call to activate the catheterization lab for PCI treatment (92 percent).
- Permitting the emergency department physician to activate the cath lab without consulting a cardiologist (87 percent) and allowing the cath lab to be activated without cardiology consult prior to the patient arriving at the hospital (78 percent).
- Participating in a data collection registry (84 percent).
The most common barrier to implementing systems was competition among hospitals (37 percent) and cardiology groups (21 percent). Twenty-six percent of the systems have difficulties with EMS transport and finances.
“It’s essential to get competing hospitals and separate EMS agencies within a community to work as a team to provide optimal care for heart attack patients,” said James G. Jollis, M.D., the study’s lead author and professor of medicine at Duke University Medical Center in Durham, N.C. “These study findings can serve as a benchmark and lessons learned as additional communities across the country create their own systems of coordinated, integrated, evidence-based care for STEMI patients.”
PCI hospitals (84 percent) and/or cardiology practices (23 percent) provided funding for most of the systems.
More than 580 community-based STEMI systems are now registered in Mission: Lifeline, covering more than 60 percent of the U.S. population.
“Since Mission: Lifeline launched, we’ve seen major improvements in the coordinated care of heart attack patients,” said Christopher Granger, M.D., study co-author, chair of the Mission: Lifeline STEMI advisory working group and professor of medicine at Duke University Medical Center in Durham, N.C. “Paramedics are making the STEMI diagnosis earlier, patients are being transported or transferred to appropriate hospitals more quickly, and blocked arteries are being opened faster ― all translating to more lives saved.”
Using the survey as a snapshot, success can be improved upon even more to ensure that all patients are getting the recommended best practices in STEMI care, Granger said.
Co-authors are Timothy D. Henry, M.D.; Elliott M. Antman, M.D.; Peter B. Berger, M.D.; Peter Moyer, M.D.; Franklin Pratt, M.D.; Ivan C. Rokos, M.D.; Anna R. Acuña; Mayme Lou Roettig, R.N., M.S.N.; and Alice K. Jacobs, M.D. Author disclosures are on the manuscript.
The American Heart Association funded the study.
The American Heart Association/American Stroke Association receives funding mostly from individuals. Foundations and corporations donate as well, and fund specific programs and events. Strict policies are enforced to prevent these relationships from influencing the association’s science content. Financial information for the American Heart Association, including a list of contributions from pharmaceutical companies and device manufacturers, is available at www.heart.org/corporatefunding
NR12 – 1080 (CircQO/Jollis)
Additional resources, including multimedia, are included on the right column of this link:
For Media Inquiries: (214) 706-1173
For Public Inquiries: (800) AHA-USA1 (242-8721)